March 2017 - Volume 28 - Issue 3

  • Mels Sluyser, PhD
  • 0959-4973
  • 1473-5741
  • 10 / year
  • 138 of 213 Oncology
    130 of 253 Pharmacology & Pharmacy
  • 2.268
Current Issue Highlights


Construction, expression, and activity of a novel immunotoxin comprising a humanized antiepidermal growth factor receptor scFv and modified Pseudomonas aeruginosa exotoxin A

Akbari, Bahman; Farajnia, Safar; Zarghami, Nosratollah; More

Anti-Cancer Drugs . 28(3):263-270, March 2017.


5-Fluorouracil degradation rate could predict toxicity in stages II–III colorectal cancer patients undergoing adjuvant FOLFOX

Onesti, Concetta E.; Botticelli, Andrea; La Torre, Marco; More

Anti-Cancer Drugs . 28(3):322-326, March 2017.

`